drug

larotrectinib

1 story · latest Oct 22, 2026

Follow larotrectinib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Nov 2018 · NDA210861, NDA211710
Brand: Vitrakvi

Relationships

Developed by Eli Lilly

Timeline

Bayer's ON-TRK study record updated, remains active not recruiting at 54 patients

Oct 22Trial updateBayer

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.